Psychosomatic symptoms in patients suffering from morphea
https://doi.org/10.51523/2708-6011.2021-18-4-7
Abstract
Objective. To study the features of psychosomatic pathology in patients with morphea.
Materials and methods. We used the Symptom Check List-90 Revised (SCL-90-R) to assess patterns of phychological signs in 95 patients suffering from morphea. The control group included 30 respondents without the skin pathology.
Results. The patients with morphea revealed higher values in the Global Severity Index (GSI), Positive Symptom Distress Index (PSDI), Positive Symptoms Total (PST). The group of the patients with morphea showed higher distress levels according to the somatization, obsessive and compulsive disorders, depression, anxiety scales.
Conclusion. Patients with morphea have a wider range of psychosomatic symptoms. The prevalent characteristics of psychosomatic changes are somatization, obsessive and compulsive disorders, depression, anxiety.
Supporting agencies: The study was carried out as part of the work on the topic sponsored by the Gomel Regional Executive Committee Innovation Fund No.20201769 dated 09.11.2020 “To develop and implement an algorithm for the diagnosis and treatment of morphea in patients suffering from metabolic syndrome”.
About the Author
L. А. Pаroshуna
Gomel State Medical University
Belarus
Belarus
Larysa A. Paroshyna, Senior Lecturer at Department of Internal Medicine No.2 with the course of the Faculty of Professional Development and Retraining
Gomel
References
1. Novickaya NN, YAkubovich AI. Quality of life and psoriasis: psychological aspects. Sibirskij medicinskij zhurnal (Irkutsk). 2008;77(2):8-12. (In Russ.).
2. Potekaev NN, L’vov AN, Zhukova OV, Hlystova EA, Kochetkov MA, Igoshina AV. Psychosomatic disorders and quality of life in chronic dermatoses of facial localization and their dynamics against the background of the use of medical camouflage. Klinicheskaya dermatologiya i venerologiya. 2017;16(5):58-72. (In Russ.). DOI: https://doi.org/10.17116/klinderma201716558-71
3. Romanov DV. Mental disorders that occur in the space of the skin: a literature review (part 1). Psih rasstrojstva v obshchej medicine. 2014;1:37-45. (In Russ.)
4. Shavlovskaya OA. Anxiety disorders in dermatological practice. Dermatologiya. 2014;3:33-35. (In Russ.)
5. Smulevich AB, Dorozhenok IYU, Romanov DV, L’vov AN. Hypochondria sine materia as a psychosomatic problem (based on the model of hypochondriacal disorders that are realized in the space of the skin). Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2012;1:14-25. (In Russ.).
6. Efanova EN, Vasil’eva EA, Kobylyanskaya NV, Kalinin MA. Analysis of the dermatology life quality index DLQI (the dermatology life quality index) in patients with various dermatological nosologies. Mediko-farmacevticheskij zhurnal “Pul’s”. 2019:1(6):22-26. (In Russ.).
7. Batkaeva NV, Batkaev EA, Gitinova MM. Comparative assessment of the dermatological index of quality of life in patients with chronic inflammatory dermatoses. RMZH. 2018;8(II):68-71. (In Russ.).
8. Polyn IV, Poroshina LA, Tsitko NS. Assessment of psychopathological signs in young people with acne vulgaris. Dermatovenerologiya. Kosmetologiya. 2019;5(1):30-36. (In Russ.).
9. Bakalets NF, Poroshina LA. Metabolic syndrome as a risk factor for skin pathology.Health and Ecology Issues. 2018;58(4):9-15. [Date of access 2021 June 15]. Available from: https://journal.gsmu.by/jour/article/view/67 (In Russ.).
10. Muazzez Çiğdem Oba, Özge Aşkın, Burhan Engin. Morphea: Clinical Considerations and Management. J Turk Acad Dermatol. 2020;14(1):1-5. DOI: https://doi.org/10.4274/jtad.galenos.2020.70299
11. Kafaja S, Clements P. Management of widespread skin thickening in diffuse systemic sclerosis. Curr. Treatm. Opt. Rheumatol. 2016;2(1):49-60. DOI: https://doi.org/10.1007/s40674-016-0040-0
12. Methodology: Questionnaire of the severity of psychopathological symptoms (SYMPTOM CHECK LIST-90- REVISED - SCL-90-R). Psychological diagnostics. [date of access 2021 June 15]. Available from: https://www.sites.google.com/site/test300m/
13. Derogatis LR, Unger R. Symptom Checklist-90-Re- vised [date of access 2021 June 15]. Available from: https://www.researchgate.net/publication/228040890_Symptom_Checklist-90-
14. Yusupova LA, Abdrahmanov RM. Psychodiagnostics and psychocorrection in dermatocosmetology. Study guide for students of postgraduate and additional professional education. Moscow, KSMU; 2011: 64 p. (In Russ.)
15. Dorozhenok IYU. Mental disorders comorbid with chronic dermatoses. Obozrenie psihiatrii i medicinskoj psihologii imeni V.M. Bekhtereva. 2009;3:18-25. (In Russ.)
16. Karavaeva TA, Korol’kova TN. Psychological mechanisms and psychosomatic relationships in various dermatoses. Klinicheskaya dermatologiya i venerologiya. 2018;17(5):7-16. DOI: https://doi.org/10.17116/klinderma2018170517 (In Russ.)
17. Tkachenko SB, Potekaev NN. Aging of the skin. Free radical theory. Klinicheskaya dermatologiya i venerologiya. 2003;4:85-88. (In Russ.)
18. Jafferany M. Psychodermatol: A Guide to Understanding Common Psychocutaneous Disorders. Prim Care Companion. J Clin Psychiat. 2007;9(3):203-213. DOI: https://doi.org/10.4088/pcc.v09n0306
Review
For citations:
Pаroshуna L.А. Psychosomatic symptoms in patients suffering from morphea. Health and Ecology Issues. 2021;18(4):55-60. (In Russ.) https://doi.org/10.51523/2708-6011.2021-18-4-7
Views: 475
Email this article 